EARNINGSBig Tech earnings, a Fed meeting, and inflation data converge in the week aheadJul 27DEALSIMIT0542 declares $82.37 cash dividend, payment set for July 30Jul 26DEALSLeBron James to sign with Philadelphia 76ers on reported two-year, $8 million dealJul 26MACROBrent crude slides 4.4% at the open as U.S.-Iran war pause extendsJul 26MACROBombing halt without an escalation commitment, sources sayJul 26DEALSPCGLX monthly dividend set at $0.0274 per share, payment date July 23Jul 26WORLDEmily Tanner's Instagram Q&A surfaces the part of PGA Tour life the leaderboard missesJul 26CRYPTOSam Altman's World raises $52.5 million in crypto saleJul 26DEALSPhillies rule out newly-acquired righty after season-ending injuryJul 26MACROStrait of Hormuz strike pause in focus as CENTCOM commander calls operations completeJul 26EARNINGSBig Tech earnings, a Fed meeting, and inflation data converge in the week aheadJul 27DEALSIMIT0542 declares $82.37 cash dividend, payment set for July 30Jul 26DEALSLeBron James to sign with Philadelphia 76ers on reported two-year, $8 million dealJul 26MACROBrent crude slides 4.4% at the open as U.S.-Iran war pause extendsJul 26MACROBombing halt without an escalation commitment, sources sayJul 26DEALSPCGLX monthly dividend set at $0.0274 per share, payment date July 23Jul 26WORLDEmily Tanner's Instagram Q&A surfaces the part of PGA Tour life the leaderboard missesJul 26CRYPTOSam Altman's World raises $52.5 million in crypto saleJul 26DEALSPhillies rule out newly-acquired righty after season-ending injuryJul 26MACROStrait of Hormuz strike pause in focus as CENTCOM commander calls operations completeJul 26

Novo's Wegovy Pill Still Leads the GLP-1 Pill Market as Lilly's Foundayo Launches

Novo Nordisk's Wegovy pill remains a top choice among Americans for weight loss even after the launch of Foundayo, Eli Lilly's GLP-1 pill, according to MarketWatch.

By StaffMacro DeskJune 9, 20262 min readNVO ·LLY
Share